|1.||Asamura, Hisao: 2 articles (11/2014 - 09/2014)|
|2.||Crowley, John: 2 articles (11/2014 - 09/2014)|
|3.||Petrović, Milica: 1 article (02/2015)|
|4.||Rabrenović, Milorad: 1 article (02/2015)|
|5.||Rabrenović, Violeta: 1 article (02/2015)|
|6.||Antić, Svetlana: 1 article (02/2015)|
|7.||Pilcević, Dejan: 1 article (02/2015)|
|8.||Ignjatović, Ljiljana: 1 article (02/2015)|
|9.||Jovanović, Dragan: 1 article (02/2015)|
|10.||Marjanović, Slobodan: 1 article (02/2015)|
01/01/1999 - "Prosorba(R) appears effective for predominantly sensory demyelinating polyneuropathies associated with M-components of all major immunoglobulin classes. "
12/01/1993 - "Immunofixation superior to plasma agarose electrophoresis in detecting small M-components in patients with polyneuropathy."
12/01/1988 - "Peripheral polyneuropathy, a rare complication of multiple myeloma, is generally associated with heavy-chain M-proteins and, in very rare instances, with free light-chain myeloma proteins. "
12/01/1993 - "Two of these 5 patients, one with an axonal polyneuropathy and the other with a lower motor neuron syndrome, had extra bands on agarose electrophoresis, verified as IgG M-components by immunofixation. "
12/01/1993 - "Monoclonal immunoglobulins (M-components) in blood are found in some patients with polyneuropathy and are thought to be of pathogenetic importance, especially if the M-component is of IgM isotype. "
01/01/2015 - "In 2016, the cancer registry community will directly assign T, N and M components of stage. "
09/01/2014 - "The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors."
01/01/2000 - "Among cancer sites without known association with M-components 141 cases were observed versus 94.6 expected giving a SIR of 1.5 (1. 3-1.8). "
01/01/2000 - "In the MGUS cohort 64 new cancers with a known association with M-components were diagnosed versus 5.0 expected giving a standardized incidence ratio (SIR) of 12.9 (95% confidence interval, 9.9-16.5). "
07/01/1993 - "The urine samples came from patients with serum M components associated with neoplasms of either plasma cells (n = 2) or lymphocytes (n = 2) or with M components of undetermined significance (n = 6). "
04/01/1996 - "The presence of two M components in the serum or urine (double gammopathy) in multiple myeloma constitutes an uncommon event. "
09/01/1986 - "Plasma cell myeloma and the myeloma proteins."
12/01/1981 - "The importance of M-components in patients with multiple myeloma--two illustrative case reports."
09/01/1981 - "Multiple myeloma with discordant M components in the serum and CSF."
12/01/1970 - "Significance of M-components in plasma cell myeloma and related disorders."
|5.||Paraproteinemias (Monoclonal Gammopathy)
05/01/1986 - "A retrospective review of 1135 patients with paraproteinemias recorded 28 (2.5%) as having two M components. "
01/01/1972 - "Frequency of monoclonal gammapathy ('M components') in 13,400 sera from blood donors."
08/01/2005 - "Plasmapheresis is an established method to treat patients with large monoclonal gammopathies (M-components) that increases the blood viscosity. "
05/01/1996 - "In the present study T cell stimulation induced by idiotypic determinants on the autologous monoclonal IgG (M-components) from patients with monoclonal gammopathies was studied. "
05/01/1983 - "On the other hand, carbohydrate-rich M components of immunoglobulins M and A in serum and in cerebrospinal fluid from patients with plasma cell dyscrasia are readily detected. "
|1.||Clodronic Acid (Clodronate)
|3.||Immunoglobulin G (IgG)
|4.||Immunoglobulin A (IgA)
|6.||Immunoglobulin Variable Region
|9.||Proteins (Proteins, Gene)
|10.||Immunoglobulin M (IgM)
|1.||Drug Therapy (Chemotherapy)
|3.||Stem Cell Transplantation